H. Corvol

M. Knowles, S. Ling, P. Durie, 2016, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

FAM13A is a modifier gene of cystic fibrosis lung phenotype regulating rhoa activity, actin cytoskeleton dynamics and epithelial-mesenchymal transition.

M. Drumm, C. Hodges, P. Böelle, 2018, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

New insights into pediatric idiopathic pulmonary hemosiderosis: the French RespiRare(R) cohort

P. Reix, R. Epaud, A. Clément, 2018 .

New insights into pediatric idiopathic pulmonary hemosiderosis: the French RespiRare® cohort

P. Reix, R. Epaud, A. Clément, 2013, Orphanet Journal of Rare Diseases.

Alveolar epithelial cells: master regulators of lung homeostasis.

L. Guillot, S. Amselem, A. Clément, 2013, The international journal of biochemistry & cell biology.

Glucocorticoids reduce inflammation in cystic fibrosis bronchial epithelial cells.

D. Ray, L. Guillot, A. Clément, 2012, Cellular signalling.

Severe central apnea secondary to cerebellar dysplasia in a child: look past Joubert syndrome.

D. Rodriguez, P. Bokov, H. Corvol, 2020, Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine.

SARS-CoV-2 B.1.1.529 (Omicron) Variant Causes an Unprecedented Surge in Children Hospitalizations and Distinct Clinical Presentation Compared to the SARS-CoV-2 B.1.617.2 (Delta) Variant

G. Thouvenin, H. Corvol, N. Nathan, 2022, Frontiers in Pediatrics.

Genetic ancestry modifies pharmacogenetic gene–gene interaction for asthma

E. Ziv, E. Burchard, S. Choudhry, 2009, Pharmacogenetics and genomics.

Modifier genes in cystic fibrosis-related liver disease

H. Corvol, C. Housset, D. Debray, 2019, Current opinion in gastroenterology.

AGER -429T/C Is Associated with an Increased Lung Disease Severity in Cystic Fibrosis

P. Böelle, P. Reix, J. Dalphin, 2012, PloS one.

RSPH3 Mutations Cause Primary Ciliary Dyskinesia with Central-Complex Defects and a Near Absence of Radial Spokes.

S. Amselem, A. Clément, B. Copin, 2015, American journal of human genetics.

Flagellin concentrations in expectorations from cystic fibrosis patients

R. Ramphal, M. Chignard, A. Clément, 2014, BMC Pulmonary Medicine.

Distinct cytokine production by lung and blood neutrophils from children with cystic fibrosis.

J. Cavaillon, A. Clément, C. Fitting, 2003, American journal of physiology. Lung cellular and molecular physiology.

Pharmacogenetic response to albuterol among asthmatics.

E. Burchard, H. Corvol, 2008, Pharmacogenomics.

Benefits and risks of bronchoalveolar lavage in severe asthma in children

H. Corvol, N. Nathan, J. Taytard, 2021, ERJ Open Research.

Adherence of airway neutrophils and inflammatory response are increased in CF airway epithelial cell-neutrophil interactions.

J. Cavaillon, A. Clément, C. Fitting, 2006, American journal of physiology. Lung cellular and molecular physiology.

Risk factors for admission to the pediatric critical care unit among children hospitalized with COVID-19 in France

S. Tezenas du Montcel, X. Lenne, H. Corvol, 2022, Frontiers in Pediatrics.

Flagellin from Pseudomonas aeruginosa modulates SARS-CoV-2 infectivity in CF airway epithelial cells by increasing TMPRSS2 expression

L. Guillot, M. Rosa-Calatrava, H. Corvol, 2020 .

Flagellin from Pseudomonas aeruginosa modulates SARS-CoV-2 infectivity in CF airway epithelial cells by increasing TMPRSS2 expression

L. Guillot, M. Rosa-Calatrava, H. Corvol, 2020, bioRxiv.

Pulmonary hemosiderosis in children with Down syndrome: a national experience

P. Reix, R. Epaud, A. Clément, 2018, Orphanet Journal of Rare Diseases.

ALOX5AP and LTA4H polymorphisms modify augmentation of bronchodilator responsiveness by leukotriene modifiers in Latinos.

E. Burchard, W. Rodriguez-Cintron, R. Chapela, 2010, The Journal of allergy and clinical immunology.

The role of LTA4H and ALOX5AP genes in the risk for asthma in Latinos

W. Rodriguez-Cintron, R. Chapela, J. Galanter, 2010, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

SLC6A14 Impacts Cystic Fibrosis Lung Disease Severity via mTOR and Epithelial Repair Modulation

P. Böelle, L. Guillot, E. Sutanto, 2021, Frontiers in Molecular Biosciences.

SLC6A14 Modulates Lung Disease Severity in Cystic Fibrosis and Affects mTOR Phosphorylation and Bronchial Epithelial Repair

P. Böelle, L. Guillot, E. Sutanto, 2021 .

Cumulative Incidence and Risk Factors for Severe COVID-19 in French People with Cystic Fibrosis

P. Reix, P. Burgel, C. Marguet, 2022, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Reference percentiles for FEV1 and BMI in European children and adults with cystic fibrosis

M. Mei-Zahav, J. Vibert, P. Böelle, 2012, Orphanet Journal of Rare Diseases.

Lung sarcoidosis in children: update on disease expression and management

R. Epaud, A. Clément, P. Busson, 2015, Thorax.

Clinical response to lumacaftor-ivacaftor in patients with cystic fibrosis according to baseline lung function.

P. Reix, P. Burgel, J. Paillasseur, 2020, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

Chest physiotherapy enhances detection of Pseudomonas aeruginosa in nonexpectorating children with cystic fibrosis

P. Reix, I. Pin, C. Marguet, 2021, ERJ Open Research.

Dramatic improvement after tocilizumab of severe COVID‐19 in a child with sickle cell disease and acute chest syndrome

H. Ducou le Pointe, H. Corvol, N. Nathan, 2020, American journal of hematology.

Clinical characteristics of SARS-CoV-2 infection in children with cystic fibrosis: An international observational study

C. Goss, P. Burgel, M. Salvatore, 2020, Journal of Cystic Fibrosis.

Factors associated with clinical progression to severe COVID-19 in people with cystic fibrosis: A global observational study

C. Goss, H. Rodgers, P. Burgel, 2022, Journal of Cystic Fibrosis.

Circulating and airway neutrophils in cystic fibrosis display different TLR expression and responsiveness to interleukin-10.

J. Cavaillon, A. Clément, H. Corvol, 2008, Cytokine.

Influence of interleukin-10 on Aspergillus fumigatus infection in patients with cystic fibrosis.

C. Flamant, P. Boelle, A. Clément, 2005, The Journal of infectious diseases.

The Proceedings of the 16th Italian Convention of Investigators in Cystic Fibrosis

L. Strug, A. Bragonzi, G. Cabrini, 2019, Multidisciplinary Respiratory Medicine.

Anoctamin 1 dysregulation alters bronchial epithelial repair in cystic fibrosis.

L. Guillot, A. Clément, E. Naline, 2013, Biochimica et biophysica acta.

Respiratory management of spinal muscular atrophy type 1 patients treated with Nusinersen

L. Servais, L. Coutier, H. Corvol, 2022, Pediatric pulmonology.

The global impact of SARS-CoV-2 in 181 people with cystic fibrosis

C. Goss, H. Rodgers, P. Burgel, 2020, Journal of Cystic Fibrosis.

A rare CFTR intronic mutation related to a mild CF disease in a 12-year-old girl

A. Clément, E. Girodon, H. Corvol, 2012, BMJ Case Reports.

Unusual presentation of more common disease/injury A rare CFTR intronic mutation related to a mild CF disease in a 12-year-old girl

A. Clément, E. Girodon, H. Corvol, 2012 .

Cystic fibrosis gene modifier SLC26A9 modulates airway response to CFTR-directed therapeutics

J. Rommens, P. Böelle, L. Strug, 2016, Human molecular genetics.

Real-Life Safety and Effectiveness of Lumacaftor-Ivacaftor in Patients with Cystic Fibrosis.

D. Caimmi, A. Didier, S. Leroy, 2020, American journal of respiratory and critical care medicine.

Modifier Factors of Cystic Fibrosis Phenotypes: A Focus on Modifier Genes

L. Guillot, H. Corvol, M. Ruffin, 2022, International journal of molecular sciences.

Are CF carriers predisposed to asthma?

L. Guillot, H. Corvol, 2016, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

SARS-CoV-2 variant Delta infects all 6 siblings but spares Comirnaty (BNT162b2, BioNTech/Pfizer)-vaccinated parents

H. Corvol, N. Nathan, A. Schnuriger, 2021, The Journal of infectious diseases.

410: Pseudomonas aeruginosa modulates SARS-CoV-2 infectivity in CF airway epithelial cells by increasing expression of the host protease TMPRSS2

L. Guillot, M. Rosa-Calatrava, H. Corvol, 2021, Journal of Cystic Fibrosis.

Respiratory Epithelial Cells Can Remember Infection: A Proof of Concept Study.

L. Guillot, M. Chignard, C. Hennequin, 2019, The Journal of infectious diseases.

First Wave of COVID-19 in French Patients with Cystic Fibrosis

P. Boelle, P. Burgel, L. Guillot, 2020, Journal of clinical medicine.

The Wide Spectrum of COVID-19 Clinical Presentation in Children

G. Thouvenin, H. Corvol, N. Nathan, 2020, Journal of clinical medicine.

A multinational report to characterise SARS-CoV-2 infection in people with cystic fibrosis

C. Goss, H. Rodgers, P. Burgel, 2020, Journal of Cystic Fibrosis.

Interstitial lung diseases in children

R. Epaud, A. Clément, B. Fauroux, 2010, Orphanet journal of rare diseases.

Lung alveolar epithelium and interstitial lung disease.

L. Guillot, R. Epaud, A. Clément, 2009, The international journal of biochemistry & cell biology.

[National consensus regarding the prescription of inhaled corticosteroids in cystic fibrosis].

H. Corvol, S. Bui, R. Chiron, 2014, Archives de pediatrie : organe officiel de la Societe francaise de pediatrie.

Atypical presentation of COVID-19 in young infants

H. Corvol, N. Nathan, Blandine Prévost, 2020, The Lancet.

Infant bronchiolitis dramatically reduced during the second French COVID‐19 outbreak

R. Guedj, P. Léger, H. Corvol, 2021, Acta paediatrica.

COVID‐19 and pediatric pulmonology: Feedback from an expert center after the first year of the pandemic

G. Thouvenin, H. Corvol, N. Nathan, 2022, Pediatric pulmonology.

Achromobacter xylosoxidans airway infection is associated with lung disease severity in children with cystic fibrosis

I. Sermet-Gaudelus, G. Thouvenin, H. Corvol, 2021, ERJ Open Research.

Variants in Solute Carrier SLC26A9 Modify Prenatal Exocrine Pancreatic Damage in Cystic Fibrosis.

Melissa R. Miller, J. Rommens, M. Drumm, 2015, The Journal of pediatrics.

MicroRNA-9 downregulates the ANO1 chloride channel and contributes to cystic fibrosis lung pathology

N. Rousselet, H. Corvol, O. Tabary, 2017, Nature Communications.

Bronchial Epithelial Cells from Cystic Fibrosis Patients Express a Specific Long Non-coding RNA Signature upon Pseudomonas aeruginosa Infection

Vinod Scaria, V. Scaria, L. Guillot, 2017, Front. Cell. Infect. Microbiol..

Macrolides: new therapeutic perspectives in lung diseases.

L. Guillot, A. Clément, H. Corvol, 2011, The international journal of biochemistry & cell biology.

Interstitial lung disease: physiopathology in the context of lung growth.

A. Clément, B. Fauroux, G. Thouvenin, 2011, Paediatric respiratory reviews.

New insights about miRNAs in cystic fibrosis.

N. Rousselet, L. Guillot, H. Corvol, 2015, The American journal of pathology.

Cystic fibrosis–related diabetes onset can be predicted using biomarkers measured at birth

J. Rommens, L. Strug, G. Cutting, 2021, Genetics in Medicine.

Genetic modifiers of cystic fibrosis-related diabetes have extensive overlap with type 2 diabetes and related traits.

J. Rommens, M. Drumm, E. Pugh, 2019, The Journal of clinical endocrinology and metabolism.

Genetic association and transcriptome integration identify contributing genes and tissues at cystic fibrosis modifier loci

J. Rommens, M. Drumm, L. Strug, 2019, PLoS genetics.

SLC26A9 Gene Is Associated With Lung Function Response to Ivacaftor in Patients With Cystic Fibrosis

P. Böelle, L. Strug, L. Guillot, 2018, Front. Pharmacol..

Improving imputation in disease-relevant regions: lessons from cystic fibrosis

J. Rommens, L. Strug, Lizhen Xu, 2018, npj Genomic Medicine.

Genome-wide association meta-analysis identifies five modifier loci of lung disease severity in cystic fibrosis

J. Rommens, M. Drumm, F. Wright, 2015, Nature Communications.

DNA methylation at modifier genes of lung disease severity is altered in cystic fibrosis

D. Caimmi, S. Leroy, L. Guillot, 2017, Clinical Epigenetics.

Glucocorticoid receptor gene polymorphisms associated with progression of lung disease in young patients with cystic fibrosis

P. Boelle, A. Clément, B. Fauroux, 2007, Respiratory research.

Two-hybrid screening of FAM13A protein partners in lung epithelial cells

L. Guillot, H. Corvol, Kristin E. Thompson, 2019, BMC Research Notes.

Massive splenomegaly and pancytopenia reuealing sarcoidosis in a child.

R. Epaud, A. Clément, A. Coulomb, 2013, Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG.

Whole exome sequencing in three families segregating a pediatric case of sarcoidosis

J. Bernaudin, S. Pinson, V. Cottin, 2018, BMC Medical Genomics.

Cystic Fibrosis Liver Disease: Outcomes and Risk Factors in a Large Cohort of French Patients

P. Böelle, L. Guillot, A. Clément, 2018, Hepatology.

AGTR2 absence or antagonism prevents cystic fibrosis pulmonary manifestations.

Michael R Knowles, Abdus Sattar, Mitchell L Drumm, 2019, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

Leveraging TOPMed imputation server and constructing a cohort-specific imputation reference panel to enhance genotype imputation among cystic fibrosis patients

M. Bamshad, Yun Li, E. Pugh, 2021, bioRxiv.

A national internet-linked based database for pediatric interstitial lung diseases: the French network

C. Delacourt, J. Vibert, P. Reix, 2012, Orphanet Journal of Rare Diseases.

An idiopathic congenital chylothorax: surgery or conservative management?

H. Corvol, N. Nathan, M. Larroquet, 2014, BMJ Case Reports.

Hordeum murinum aspiration revealed by a pneumopleurocutaneous fistula in a 15-month-old infant

H. Ducou le Pointe, H. Corvol, N. Richard, 2021, BMC Pediatrics.

Gene Therapy: A Possible Alternative to CFTR Modulators?

L. Guillot, H. Corvol, M. Ruffin, 2021, Frontiers in Pharmacology.

Ancestral haplotype 8.1 and lung disease severity in European cystic fibrosis patients.

P. Böelle, C. Palmer, A. Clément, 2012, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

Factors for severe outcomes following SARS-CoV-2 infection in people with cystic fibrosis in Europe

M. Mei-Zahav, P. Yiallouros, P. Dřevínek, 2021, ERJ Open Research.

Airway Mucosal Host Defense Is Key to Genomic Regulation of Cystic Fibrosis Lung Disease Severity

M. Drumm, F. Wright, P. Gallins, 2018, American journal of respiratory and critical care medicine.

Multiple-Locus Variable-Number Tandem-Repeat Analysis for Longitudinal Survey of Sources of Pseudomonas aeruginosa Infection in Cystic Fibrosis Patients

G. Vergnaud, A. Clément, C. Pourcel, 2007, Journal of Clinical Microbiology.

Lessons from a French collaborative case–control study in cystic fibrosis patients during the 2009 A/H1N1 influenza pandemy

P. Boelle, I. Durieu, N. Stremler, 2015, BMC Infectious Diseases.

Small RNA and transcriptome sequencing reveal the role of miR‐199a‐3p in inflammatory processes in cystic fibrosis airways

N. Rousselet, P. Bardin, H. Corvol, 2018, The Journal of pathology.

Longitudinal survey of Staphylococcus aureus in cystic fibrosis patients using a multiple-locus variable-number of tandem-repeats analysis method

G. Vergnaud, C. Pourcel, B. Fauroux, 2010, BMC Microbiology.

Opposite Expression of Hepatic and Pulmonary Corticosteroid-Binding Globulin in Cystic Fibrosis Patients

N. Rousselet, L. Guillot, M. Moisan, 2018, Front. Pharmacol..

CHAC1 Is Differentially Expressed in Normal and Cystic Fibrosis Bronchial Epithelial Cells and Regulates the Inflammatory Response Induced by Pseudomonas aeruginosa

L. Touqui, I. Mungrue, L. Guillot, 2018, Front. Immunol..

Genetic variation in CFTR and modifier loci may modulate cystic fibrosis disease severity.

A. Harris, H. Corvol, A. Paranjapye, 2019, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

Translating the genetics of cystic fibrosis to personalized medicine.

L. Guillot, H. Corvol, O. Tabary, 2016, Translational research : the journal of laboratory and clinical medicine.

Variant classifications, databases and genotype-phenotype correlations.

C. Raynal, H. Corvol, 2020, Archives de pediatrie : organe officiel de la Societe francaise de pediatrie.

Impact of the COVID-19 pandemic and associated lockdown measures on the management, health, and behavior of the cystic fibrosis population in France during 2020 (MUCONFIN)

R. Epaud, D. Grenet, G. Thouvenin, 2022, Frontiers in Public Health.

Lung disease modifier genes in cystic fibrosis.

L. Guillot, A. Clément, H. Corvol, 2014, The international journal of biochemistry & cell biology.

Genetic variations in inflammatory mediators influence lung disease progression in cystic fibrosis

C. Flamant, P. Boelle, A. Clément, 2008, Pediatric pulmonology.

Improving imputation in disease-relevant regions: lessons from cystic fibrosis

S. Scherer, J. Rommens, M. Drumm, 2018, npj Genomic Medicine.

Risk factors for Pseudomonas aeruginosa airway infection and lung function decline in children with cystic fibrosis.

P. Böelle, L. Guillot, H. Corvol, 2021, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

Emerging microRNA Therapeutic Approaches for Cystic Fibrosis

P. Bardin, H. Corvol, O. Tabary, 2018, Front. Pharmacol..

Normal and Cystic Fibrosis Human Bronchial Epithelial Cells Infected with Pseudomonas aeruginosa Exhibit Distinct Gene Activation Patterns

J. Coppee, L. Guillot, M. Chignard, 2015, PloS one.

Retrospective observational study of the influence of the COVID-19 outbreak on infants’ hospitalisation for acute bronchiolitis

R. Guedj, H. Corvol, M. Lorrot, 2022, BMJ Open.

Long-term effects of azithromycin in patients with cystic fibrosis.

P. Boelle, A. Clément, H. Corvol, 2016, Respiratory medicine.

Stenotrophomonas maltophilia: A marker of lung disease severity

P. Boelle, A. Clément, H. Corvol, 2018, Pediatric pulmonology.

Neutrophils in Cystic Fibrosis Display a Distinct Gene Expression Pattern

J. Cavaillon, A. Clément, H. Corvol, 2008, Molecular medicine.

Sources of Variation in Sweat Chloride Measurements in Cystic Fibrosis.

J. Rommens, P. Boelle, L. Strug, 2016, American journal of respiratory and critical care medicine.

Short Communication Ancestral haplotype 8.1 and lung disease severity in European cystic fibrosis patients

P. Böelle, A. Clément, J. Elborn, 2012 .

Evaluation of the trachea and intrathoracic airways by the acoustic reflection method in children with cystic fibrosis

F. Lofaso, B. Fauroux, R. Fodil, 2012, Respiratory Physiology & Neurobiology.

HRCT and MRI of the lung in children with cystic fibrosis: comparison of different scoring systems.

P. Boelle, A. Clément, E. Blondiaux, 2014, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

Nocturnal hypoventilation in Down syndrome children with or without sleep apnea

H. Corvol, J. Taytard, N. Beydon, 2020, Pediatric pulmonology.

Whole exome sequencing in three families segregating a pediatric case of sarcoidosis

J. Bernaudin, S. Pinson, V. Cottin, 2018, BMC Medical Genomics.

Cystic fibrosis gene modifier SLC26A9 modulates airway response to CFTR-directed therapeutics.

J. Rommens, P. Böelle, L. Strug, 2016, Human molecular genetics.

Factors Predisposing the Response to Lumacaftor/Ivacaftor in People with Cystic Fibrosis

P. Böelle, L. Guillot, H. Corvol, 2022, Journal of personalized medicine.

Update on SLC6A14 in lung and gastrointestinal physiology and physiopathology: focus on cystic fibrosis

L. Guillot, E. Sutanto, A. Kicic, 2020, Cellular and Molecular Life Sciences.

Effect of Flagellin Pre-Exposure on the Inflammatory and Antifungal Response of Bronchial Epithelial Cells to Fungal Pathogens

L. Guillot, C. Hennequin, H. Corvol, 2022, Journal of fungi.

A new candidate biomarker of inflammation in CF airway: Amphiregulin

J. Cavaillon, A. Clément, H. Corvol, 2008 .

Mild cystic fibrosis revealed by persistent hyponatremia during the French 2003 heat wave, associated with the S1455X C‐terminus CFTR mutation

R. Epaud, A. Clément, A. Bensman, 2005, Clinical Genetics.

COVID-19 vaccine prioritisation for people with cystic fibrosis

C. Goss, P. Burgel, M. Salvatore, 2021, Journal of Cystic Fibrosis.

P265 Real-life initiation of lumacaftor/ivacaftor in adolescents and adults homozygous for the F508del CFTR mutation: a French nationwide study

P. Reix, P. Burgel, I. Durieu, 2019, Journal of Cystic Fibrosis.

Factors associated with humoral immune response to pandemic A/H1N1(v) 2009 influenza vaccine in cystic fibrosis.

P. Böelle, P. Boelle, I. Sermet-Gaudelus, 2014, Vaccine.

Genetic Modifiers of Cystic Fibrosis Lung Disease Severity: Whole Genome Analysis of 7,840 Patients.

M. Rosenfeld, M. Bamshad, Yun Li, 2023, American journal of respiratory and critical care medicine.

SERPINA1 Z allele is associated with cystic fibrosis liver disease

P. Böelle, L. Guillot, H. Corvol, 2019, Genetics in Medicine.

Biomarkers in Interstitial lung diseases.

S. Amselem, A. Clément, H. Corvol, 2015, Paediatric respiratory reviews.

Human Bronchial Epithelial Cells Inhibit Aspergillus fumigatus Germination of Extracellular Conidia via FleA Recognition

A. Imberty, L. Guillot, M. Chignard, 2018, Scientific Reports.

Omalizumab treatment for allergic bronchopulmonary aspergillosis in young patients with cystic fibrosis.

A. Clément, I. Sermet-Gaudelus, J. Derelle, 2017, Respiratory medicine.

Ultrasonography and Computed Tomographic Manifestations of Abdominal Sarcoidosis in Children

R. Epaud, P. Tounian, E. Blondiaux, 2016, Journal of Pediatric Gastroenterology and Nutrition - JPGN.

Pulmonary sarcoid-like granulomatous disease in an 11-month-old girl

H. Corvol, N. Nathan, J. Pautrat, 2013, BMJ Case Reports.

Interstitial lung diseases

A. Clément, G. Thouvenin, H. Corvol, 2021, ERS Handbook of Paediatric Respiratory Medicine.

Vaccine coverage in CF children: A French multicenter study.

I. Sermet-Gaudelus, O. Launay, H. Corvol, 2015, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

WS07.02 Lumacaftor/ivacaftor in people with cystic fibrosis: factors predisposing the response and impact on lung function decline

P. Boelle, L. Guillot, H. Corvol, 2022, Journal of Cystic Fibrosis.

Human Bronchial Epithelial Cells Inhibit Aspergillus fumigatus Germination of Extracellular Conidia via FleA Recognition

Christophe Hennequin, Anne Imberty, Annabelle Varrot, 2018, Scientific Reports.

Pulmonary Hemorrhage Revealing Multiple Vascular Malformations in a Child With KCNT1 Developmental Epileptic Encephalopathy.

H. Corvol, C. Mignot, D. Doummar, 2021, The Journal of pediatrics.

Airway infections as a risk factor for Pseudomonas aeruginosa acquisition and chronic colonisation in children with cystic fibrosis.

P. Böelle, L. Guillot, H. Corvol, 2023, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

Stenotrophomonas maltophilia: A marker of lung disease severity

P. Boelle, A. Clément, H. Corvol, 2018, Pediatric pulmonology.

Translating the genetics of cystic fibrosis to personalized medicine.

L. Guillot, H. Corvol, O. Tabary, 2016, Translational research : the journal of laboratory and clinical medicine.

Novel variation at chr11p13 associated with cystic fibrosis lung disease severity

M. Drumm, P. Gallins, L. Strug, 2016, Human Genome Variation.

FAM13A is a modifier gene of cystic fibrosis lung phenotype regulating rhoa activity, actin cytoskeleton dynamics and epithelial-mesenchymal transition.

M. Drumm, C. Hodges, P. Böelle, 2018, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

Macrolides: new therapeutic perspectives in lung diseases.

L. Guillot, A. Clément, H. Corvol, 2011, The international journal of biochemistry & cell biology.

The omicron wave modifies the COVID-19 paradigm in children with cystic fibrosis

G. Thouvenin, H. Corvol, Blandine Prévost, 2022, Journal of Infectious Diseases.

Genetic ancestry modifies pharmacogenetic gene–gene interaction for asthma

E. Ziv, E. Burchard, S. Choudhry, 2009, Pharmacogenetics and genomics.

Interstitial lung disease: physiopathology in the context of lung growth.

A. Clément, B. Fauroux, G. Thouvenin, 2011, Paediatric respiratory reviews.

Biomarkers in Interstitial lung diseases.

S. Amselem, A. Clément, H. Corvol, 2015, Paediatric respiratory reviews.

Flagellin from Pseudomonas aeruginosa increases the expression of the SARS-CoV2 entry protease TMPRSS2 in airway epithelial cells

H. Corvol, J. Bigot, V. Balloy, 2020 .

[Update of the 2021 Recommendations for the management of and follow-up of adolescent asthmatic patients (over 12 years) under the guidance of the French Society of Pulmonology and the Paediatric Society of Pulmonology and Allergology. Long version].

R. Epaud, C. Marguet, A. Deschildre, 2022, Revue des maladies respiratoires.

Multiple-Locus Variable-Number Tandem-Repeat Analysis for Longitudinal Survey of Sources of Pseudomonas aeruginosa Infection in Cystic Fibrosis Patients

G. Vergnaud, A. Clément, C. Pourcel, 2007, Journal of Clinical Microbiology.

Sweat test practice in pediatric pulmonology after introduction of cystic fibrosis newborn screening

P. Reix, I. Pin, J. Dubus, 2015, European Journal of Pediatrics.